The landscape of managing patients with COVID-19 continues to change. New research suggests acute medical illness, such as COVID-19, and hospitalisation confer a greater risk of venous thromboembolism (VTE). Also, Coagulopathy in COVID-19 patients appears to be associated with poor prognosis, an effect common in patients with sepsis. Read more
The International Society of Thrombosis and Haemostasis has released information on COVID-19 and thrombosis. Here are the important facts; Having a blood clot does not increase your risk of acquiring COVID-19. Taking anticoagulants (blood-thinning medication) for a blood clot disorder also does not increase your risk of acquiring COVID-19. Read more
Perth Blood Institute is pleased to announce it is the recipient of the Norma Beaconsfield Project Grant, awarded by the Dementia Australia Research Foundation (DARF). This grant will allow the Platelet Research Team to continue important investigations into the effect of blood-thinning medication on dementia risk. Read more
Some members of the community may be concerned about the potential transmission of the COVID-19 virus through blood products, such as through blood transfusions. If you rely on blood products, you should feel confident to continue to receive them. Read more
Australians are set to benefit from a central resource ‘hub’ of authoritative information to increase awareness and understanding of deep vein thrombosis, pulmonary embolism and stroke, and improve their prevention, early detection and management. Read more
Perth Blood Institute has participated in a ground-breaking clinical trial which has uncovered a new life-changing treatment for people with haemophilia. Read more
Pancreatic cancer is one of the deadliest diseases. A recent study led by PBI Scientist Dr Omar Elaskalani has been published in a special issue of Cancers by MDPI, a peer-reviewed academic journal. The study offers promising evidence that a commonly used blood thinner may help pancreatic cancer patients. Read more
PBI conducted a laboratory workshop for year 11 high school students thinking about a career in science on 12 October 2019. This hands- on workshop enabled students to conduct experiments on flow cytometry and ABO blood group typing as well as find out why people bleed. Read more
PBI was fortunate to have renowned haemophilia expert Professor Midori Shima of Japan present his research findings at the PBI Education Dinner held on Saturday 19th October 2019 at the Parmelia Hilton Perth Hotel. Read more
Congratulations to PBI Research Scientist Omar Elaskalani, winner of the 2019 THANZ medal for best presentation at the recent Blood 2019 Conference held in Perth. Omar’s research outcomes will influence treatment options for patients in the future. Read more